Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy

Xiaoxia Cai, Qingxia Zhu, Yun Zeng, Qi Zeng, Xueli Chen, Yonghua Zhan Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Science and Technology, Xidian University, Xi’an, Shaanxi, People’s Republic of ChinaCorrespondence: Yongh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cai X, Zhu Q, Zeng Y, Zeng Q, Chen X, Zhan Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
MRI
Acceso en línea:https://doaj.org/article/047c0eaf35574fcb9a0cda0075dab2a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:047c0eaf35574fcb9a0cda0075dab2a8
record_format dspace
spelling oai:doaj.org-article:047c0eaf35574fcb9a0cda0075dab2a82021-12-02T05:04:38ZManganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy1178-2013https://doaj.org/article/047c0eaf35574fcb9a0cda0075dab2a82019-10-01T00:00:00Zhttps://www.dovepress.com/manganese-oxide-nanoparticles-as-mri-contrast-agents-in-tumor-multimod-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xiaoxia Cai, Qingxia Zhu, Yun Zeng, Qi Zeng, Xueli Chen, Yonghua Zhan Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Science and Technology, Xidian University, Xi’an, Shaanxi, People’s Republic of ChinaCorrespondence: Yonghua ZhanEngineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Science and Technology, Xidian University, Xi’an, Shaanxi 710071, People’s Republic of ChinaTel +86 29 81891070Fax +86 29 81891060Email yhzhan@xidian.edu.cnAbstract: Contrast agents (CAs) play a crucial role in high-quality magnetic resonance imaging (MRI) applications. At present, as a result of the Gd-based CAs which are associated with renal fibrosis as well as the inherent dark imaging characteristics of superparamagnetic iron oxide nanoparticles, Mn-based CAs which have a good biocompatibility and bright images are considered ideal for MRI. In addition, manganese oxide nanoparticles (MONs, such as MnO, MnO2, Mn3O4, and MnOx) have attracted attention as T1-weighted magnetic resonance CAs due to the short circulation time of Mn(II) ion chelate and the size-controlled circulation time of colloidal nanoparticles. In this review, recent advances in the use of MONs as MRI contrast agents for tumor detection and diagnosis are reported, as are the advances in in vivo toxicity, distribution and tumor microenvironment-responsive enhanced tumor chemotherapy and radiotherapy as well as photothermal and photodynamic therapies.Keywords: manganese oxide nanoparticles, MRI, multimodal imaging, contrast agent, tumor therapyCai XZhu QZeng YZeng QChen XZhan YDove Medical PressarticleManganese oxide nanoparticlesMRIMultimodal imagingContrast agentTumor therapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 8321-8344 (2019)
institution DOAJ
collection DOAJ
language EN
topic Manganese oxide nanoparticles
MRI
Multimodal imaging
Contrast agent
Tumor therapy
Medicine (General)
R5-920
spellingShingle Manganese oxide nanoparticles
MRI
Multimodal imaging
Contrast agent
Tumor therapy
Medicine (General)
R5-920
Cai X
Zhu Q
Zeng Y
Zeng Q
Chen X
Zhan Y
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
description Xiaoxia Cai, Qingxia Zhu, Yun Zeng, Qi Zeng, Xueli Chen, Yonghua Zhan Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Science and Technology, Xidian University, Xi’an, Shaanxi, People’s Republic of ChinaCorrespondence: Yonghua ZhanEngineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life Science and Technology, Xidian University, Xi’an, Shaanxi 710071, People’s Republic of ChinaTel +86 29 81891070Fax +86 29 81891060Email yhzhan@xidian.edu.cnAbstract: Contrast agents (CAs) play a crucial role in high-quality magnetic resonance imaging (MRI) applications. At present, as a result of the Gd-based CAs which are associated with renal fibrosis as well as the inherent dark imaging characteristics of superparamagnetic iron oxide nanoparticles, Mn-based CAs which have a good biocompatibility and bright images are considered ideal for MRI. In addition, manganese oxide nanoparticles (MONs, such as MnO, MnO2, Mn3O4, and MnOx) have attracted attention as T1-weighted magnetic resonance CAs due to the short circulation time of Mn(II) ion chelate and the size-controlled circulation time of colloidal nanoparticles. In this review, recent advances in the use of MONs as MRI contrast agents for tumor detection and diagnosis are reported, as are the advances in in vivo toxicity, distribution and tumor microenvironment-responsive enhanced tumor chemotherapy and radiotherapy as well as photothermal and photodynamic therapies.Keywords: manganese oxide nanoparticles, MRI, multimodal imaging, contrast agent, tumor therapy
format article
author Cai X
Zhu Q
Zeng Y
Zeng Q
Chen X
Zhan Y
author_facet Cai X
Zhu Q
Zeng Y
Zeng Q
Chen X
Zhan Y
author_sort Cai X
title Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
title_short Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
title_full Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
title_fullStr Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
title_full_unstemmed Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
title_sort manganese oxide nanoparticles as mri contrast agents in tumor multimodal imaging and therapy
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/047c0eaf35574fcb9a0cda0075dab2a8
work_keys_str_mv AT caix manganeseoxidenanoparticlesasmricontrastagentsintumormultimodalimagingandtherapy
AT zhuq manganeseoxidenanoparticlesasmricontrastagentsintumormultimodalimagingandtherapy
AT zengy manganeseoxidenanoparticlesasmricontrastagentsintumormultimodalimagingandtherapy
AT zengq manganeseoxidenanoparticlesasmricontrastagentsintumormultimodalimagingandtherapy
AT chenx manganeseoxidenanoparticlesasmricontrastagentsintumormultimodalimagingandtherapy
AT zhany manganeseoxidenanoparticlesasmricontrastagentsintumormultimodalimagingandtherapy
_version_ 1718400571743928320